Voyager, Neurocrine ink gene-therapy deal
Shares of Voyager Therapeutics Inc. VYGR, +10.65% rallied 35% in premarket trading on Monday after the company announced a deal with Neurocrine Biosciences Inc. NBIX, +0.06% to develop…
Read more Voyager, Neurocrine ink gene-therapy deal